 | Up a level |
Chang, Xinyue; Liu, Xuelan; Martina, Byron; Zeltins, Andris; Augusto, Gilles; Vogel, Monique; Mohsen, Mona O; Speiser, Daniel E; Bachmann, Martin F (2023). Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation. Frontiers in immunology, 14(1114396), p. 1114396. Frontiers Research Foundation 10.3389/fimmu.2023.1114396
Rothen, Dominik A; Krenger, Pascal S; Nonic, Aleksandra; Balke, Ina; Vogt, Anne-Cathrine S; Chang, Xinyue; Manenti, Alessandro; Vedovi, Fabio; Resevica, Gunta; Walton, Senta M; Zeltins, Andris; Montomoli, Emanuele; Vogel, Monique; Bachmann, Martin F; Mohsen, Mona O (2022). Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern. Allergy, 77(8), pp. 2446-2458. Wiley 10.1111/all.15311
Vogt, Anne-Cathrine S; Jörg, Lukas; Martina, Byron; Krenger, Pascal S; Chang, Xinyue; Zeltins, Andris; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin F (2022). Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies. Frontiers in immunology, 13, p. 864718. Frontiers Research Foundation 10.3389/fimmu.2022.864718
Vogt, Anne-Cathrine S; Augusto, Gilles; Martina, Byron; Chang, Xinyue; Nasrallah, Gheyath; Speiser, Daniel E; Vogel, Monique; Bachmann, Martin F; Mohsen, Mona O (2022). Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron. Vaccines, 10(5) MDPI 10.3390/vaccines10050743
Chang, Xinyue; Liu, Xuelan; Mohsen, Mona O; Zeltins, Andris; Martina, Byron; Vogel, Monique; Bachmann, Martin F (2022). Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles. Vaccines, 10(2) MDPI 10.3390/vaccines10020307
Chang, Xinyue; Krenger, Pascal; Krüger, Caroline C; Zha, Lisha; Han, Jiami; Yermanos, Alexander; Roongta, Salony; Mohsen, Mona O; Oxenius, Annette; Vogel, Monique; Bachmann, Martin F (2022). TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization. Frontiers in immunology, 12, p. 827256. Frontiers Research Foundation 10.3389/fimmu.2021.827256
Mohsen, Mona O.; Balke, Ina; Zinkhan, Simon; Zeltina, Villija; Liu, Xuelan; Chang, Xinyue; Krenger, Pascal S.; Plattner, Kevin; Gharailoo, Zahra; Vogt, Anne-Cathrine S.; Augusto, Gilles; Zwicker, Marianne; Roongta, Salony; Rothen, Dominik A.; Josi, Romano; J. Da Costa, Joana; Sobczak, Jan M.; Nonic, Aleksandra; Brand, Lee-Anne; Nuss, Katja; ... (2022). A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2. Allergy, 77(1), pp. 243-257. Wiley 10.1111/all.15080
Vogel, Monique; Augusto, Gilles; Chang, Xinyue; Liu, Xuelan; Speiser, Daniel; Mohsen, Mona O.; Bachmann, Martin F. (2022). Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction. Allergy, 77(1), pp. 143-149. Wiley 10.1111/all.15002
Chang, Xinyue; Zeltins, Andris; Mohsen, Mona O.; Gharailoo, Zahra; Zha, Lisha; Liu, Xuelan; Walton, Senta; Vogel, Monique; Bachmann, Martin F. (2021). A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain. Vaccines, 9(11) MDPI 10.3390/vaccines9111287
Chang, Xinyue; Sousa Augusto, Gilles; Liu, Xuelan; Kündig, Thomas M; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin (2021). BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced. Allergy, 76(9), pp. 2895-2998. Wiley 10.1111/all.14893
Chang, Xinyue; Zha, Lisha; Wallimann, Alexandra; Mohsen, Mona O; Krenger, Pascal; Liu, Xuelan; Vogel, Monique; Bachmann, Martin F (2021). Low-affinity but high-avidity interactions may offer an explanation for IgE-mediated allergen cross-reactivity. Allergy, 76(8), pp. 2565-2574. Wiley 10.1111/all.14864
Liu, Xuelan; Chang, Xinyue; Rothen, Dominik; Derveni, Mariliza; Krenger, Pascal; Roongta, Salony; Wright, Edward; Vogel, Monique; Tars, Kaspars; Mohsen, Mona O.; Bachmann, Martin F. (2021). AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines, 9(4) MDPI 10.3390/vaccines9040403
Zha, Lisha; Chang, Xinyue; Zhao, Hongxin; Mohsen, Mona O.; Hong, Liang; Zhou, Yuhang; Chen, Hongquan; Liu, Xuelan; Zhang, Jie; Li, Dong; Wu, Ke; Martina, Byron; Wang, Junfeng; Vogel, Monique; Bachmann, Martin F. (2021). Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles. Vaccines, 9(4) MDPI 10.3390/vaccines9040395
Zinkhan, Simon; Ogrina, Anete; Balke, Ina; Reseviča, Gunta; Zeltins, Andris; de Brot, Simone; Lipp, Cyrill; Chang, Xinyue; Zha, Lisha; Vogel, Monique; Bachmann, Martin F.; Mohsen, Mona O. (2021). The impact of size on particle drainage dynamics and antibody response. Journal of controlled release, 331, pp. 296-308. Elsevier 10.1016/j.jconrel.2021.01.012
